Pune-based Pharma company to begin trials of medicines with potential to treat coronavirus
A total of 2,200 drugs were studied in detail, of which, 42 medicines have shown medicinal values in nullifying the coronavirus. Out of them, only three medicines gave the researches the result they were expecting.
Pune-based company Novalead Pharma Pvt Ltd has been granted permission for clinical trials on humans to find a cure for the novel coronavirus which has killed lakhs across the world.
Speaking to India Today TV, scientist Supreet Deshpande shared how the computer-generated tests have been showing positive results on the development of a medicine.
Deshpande shared that their 20 to 30 staff members started working on finding a medicine from the available medicines to fight coronavirus.
A total of 2,200 drugs were studied in detail, of which, 42 medicines have shown medicinal values in nullifying the coronavirus. Out of the 42 samples, only three medicines gave the researches the result which the scientists at Novalead were expecting.
Now, those three medicines have finally been chosen to perform clinical trials.
To carry out the cynical trials, Novalead Pharma Pvt Ltd approached the Drug Controller General of India (DCGI). It was given a go-ahead after the DCGI studied all the computer tests.
Supreet Deshpande has confirmed that the human clinical trials will commence within 20 days and hopefully, India will have the answer to fight coronavirus in the next few months.